eLife, 2021 Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death Gisby J., Clarke C., Medjeral-Thomas N. et al. Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasmaSerum | | | | |
BMC Cardiovascular Disorders, 2021 IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults Pettersson-Pablo P., Nilsson T., Breimer L. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Journal of Sleep Research, 2021 Sleep duration is associated with protein biomarkers for cardiometabolic health: A large‐scale population study Theorell‐Haglöw J., Hammar U., Lind L. et al. Olink Target 96CVDOther Diseases & SyndromesPathophysiologyPlasma | | | | |
JCI Insight, 2021 A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy da Silva Antunes R., Soldevila F., Pomaznoy M. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Biomolecules, 2021 Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans Fellström B., Helmersson-Karlqvist J., Lind L. et al. Olink Target 96NephrologyPatient StratificationUrine | | | | |
Journal of Neurochemistry, 2021 Cerebrospinal fluid and serum protein markers in autism: A co‐twin study Smedler E., Kleppe J., Neufeld J. et al. Olink Target 96NeurologyPatient StratificationSerumCSF | | | | |
Gastroenterology, 2021 Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms Livanos A., Jha D., Cossarini F. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Scientific Reports, 2021 A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk Harlid S., Harbs J., Myte R. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Arteriosclerosis, Thrombosis, and Vascular Biology, 2021 Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes Lind L., Gigante B., Borné Y. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Journal of Clinical Investigation, 2021 DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk Grasberger H., Magis A., Sheng E. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
European Journal of Heart Failure, 2021 Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction Woolley R., Ceelen D., Ouwerkerk W. et al. Olink Target 96CVDPathophysiologyPatient StratificationBlood | | | | |
Journal of Allergy and Clinical Immunology, 2021 Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis Gülen T., Teufelberger A., Ekoff M. et al. Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Scientific Reports, 2021 Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study Patel R., Lam C., Svedlund S. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Journal of Cardiac Failure, 2021 Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF Faxen U., Venkateshvaran A., Shah S. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Nature Medicine, 2021 A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity Zhou S., Butler-Laporte G., Nakanishi T. et al. Infectious DiseasesPatient Stratification | | | | |
Acta Neurologica Scandinavica, 2021 Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment Zhukovsky C., Herman S., Wiberg A. et al. Olink Target 96NeurologyPathophysiologySerum | | | | |
Inflammatory Bowel Diseases, 2021 Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease Verstockt S., Verstockt B., Machiels K. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
Diabetes, 2021 Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes Herder C., Maalmi H., Strassburger K. et al. Olink Target 96Metabolic DiseasesPathophysiologyPatient StratificationSerum | | | | |
Cancers, 2021 A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX Stroes C., Schokker S., Molenaar R. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Scientific Reports, 2021 The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients Wu P., Lin Y., Chiu Y. et al. Olink Target 96CVDRenal DiseasesPathophysiologyPlasma | | | | |